The Effect of intravenous iron on 6 minutes walk test and quality of life in patient with heart failure and iron deficiency anemia

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200102045981N1

Enrollment

100

Registered

2020-09-01

Start date

2020-07-10

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Heart failure. Condition 2: Iron deficiency anemia. Heart failure Iron deficiency anemia

Interventions

Intervention group: Patients with heart failure and iron deficiency anemia referred to Modarres hospital who are treated with Ferinject 500 or 1000 in two separate doses..

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Heart failure Iron deficiency anemia

Exclusion criteria

Exclusion criteria: Acute decompensated heart failure Allergy to injection iron

Design outcomes

Primary

Measure	Time frame
QoL according to questionnaire, 6 minutes walk test. Timepoint: 6 , 12 , 24 weeks after iron injection. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHabibollah Saadat

Shahid Beheshti University of Medical Sciences

fatememotaqi@yahoo.com+98 21 2207 4087

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026